|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's 2019 Pipeline Reportabout 7 years ago
High-Risk Marketing Violations Draw Scrutinyabout 7 years ago
Biopharma Business Checkabout 7 years ago
Patent Protection for Cannabis?about 7 years ago
Steadying the Path of Good Scienceabout 7 years ago
Southeast Biotech: Rising Tall in the Valleyabout 7 years ago
Fighting for a Streamlined European HTA Schemeabout 7 years ago
Stunted Innovation in Drug Development?about 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Roche’s Refresh
2
AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor
3
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
4
JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back
5